Vimta Labs (VIMTALABS) | Stock Overview & Key Data
Vimta Labs Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,178.00 on February 10, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Vimta Labs
VIMTALABS
|
20.49B Small-cap | 1.59% | -1.41% | 6.88% | -22.29% | -21.91% | -4.01% | 127.88% | 285.95% | 1,215.69% | 2,521.09% | 343.62% |
|
Dr. Lal PathLabs
LALPATHLAB
|
238.92B Large-cap | -2.68% | -0.79% | 11.03% | 2.56% | 3.39% | 15.37% | 59.53% | 12.09% | 223.97% | 258.78% | 258.78% |
|
Sai Life Sciences
SAILIFE
|
217.06B Large-cap | -1.11% | 4.31% | 13.24% | 28.59% | 25.33% | 53.25% | 64.85% | 64.85% | 64.85% | 64.85% | 64.85% |
|
Krsnaa Diagnostics
KRSNAA
|
19.83B Small-cap | -0.77% | -7.54% | -13.72% | -30.61% | -26.44% | -14.17% | -2.87% | -40.72% | -40.72% | -40.72% | -40.72% |
|
Suraksha Diagnostic
SURAKSHA
|
14.71B Small-cap | -1.78% | 2.04% | 8.81% | 2.83% | 6.26% | -10.99% | -31.50% | -31.50% | -31.50% | -31.50% | -31.50% |
|
Qualitek Labs
QLL
|
3.59B Small-cap | -1.91% | 13.33% | 28.71% | 4.29% | 3.82% | 41.19% | 147.07% | 147.07% | 147.07% | 147.07% | 147.07% |
Ownership & Short Interest
Calculate Your Vimta Labs Investment Returns
Long-Term Investment Performance Analysis
Vimta Labs stock price in May 2016 was ₹35.70, A ₹1,000.00 lump sum investment in Vimta Labs made 10 years ago would be worth approximately ₹14,376.75 today, representing a exceptional return of 1,337.68%. This translates to an annualized return (CAGR) of 30.51%.
10 Years Investment Scenario (May 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is VIMTALABS's 52-week high and low?
- In the last 52 weeks, Vimta Labs reached a high of ₹902.65 (on September 5, 2025) and a low of ₹376.05 (on March 30, 2026).
- What is the market cap and P/E ratio for VIMTALABS?
- Curious about Vimta Labs's size and valuation? Its market capitalization stands at 20.49B. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.76, and the forward P/E (looking ahead) is N/A.
- Does VIMTALABS pay dividends? If so, what's the yield?
- Yes, Vimta Labs is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.83%, and the company has paid an average of ₹2.00 per share annually over the past 3 years.
- Who are Vimta Labs's main competitors or similar companies to consider before investing?
When looking at Vimta Labs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB238.92B Healthcare Diagnostics & Research 15.37% 59.53% Sai Life Sciences
SAILIFE217.06B Healthcare Diagnostics & Research 53.25% 64.85% Krsnaa Diagnostics
KRSNAA19.83B Healthcare Diagnostics & Research -14.17% -2.87% Suraksha Diagnostic
SURAKSHA14.71B Healthcare Diagnostics & Research -10.99% -31.50% Qualitek Labs
QLL3.59B Healthcare Diagnostics & Research 41.19% 147.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Vimta Labs Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Vimta Labs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.78%, the Debt to Equity ratio from the most recent quarter is 1.63, and its Gross Profit Margin stands at 80.37%.
- What is the recent revenue and earnings growth for VIMTALABS?
- Looking at Vimta Labs's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.70%, and quarterly earnings saw a YoY growth of -18.20%.
- How much of VIMTALABS stock is held by insiders and institutions?
- Wondering who owns Vimta Labs stock? Company insiders (like executives and directors) hold about 65.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.16%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.